Multiple molecular signaling networks are differentially modulated in polyploid decidual cells
To gain further insights into the functions of differentially expressed genes, the functional enrichment analysis was carried out separately for the up- and down-regulated genes using the ToppFun and DAVID programs (
Tables S3 and
S4, respectively)
[37],
[38]. A summarized version of the predominantly altered signaling networks is represented in a graphical form (). Our analysis primarily categorized the genes with “Gene Ontology (GO)” terms (molecular function, biological process, and cellular component) as well as by other functional categories, such as “human phenotype,” “mouse phenotype,” “pathway,” “interaction,” “TFBS,” “coexpression,” “microRNA,” “domain,” “drug,” “gene family,” and “disease” (
Tables S3 and
S4). Under the GO: molecular function category, the up-regulated polyploidy genes consisted of major sub-categories that primarily include ATP binding, oxidoreductase activity, cofactor binding, electron carrier activity, extracellular matrix structural constituent, polysaccharide binding, vitamin binding, growth factor binding, transmembrane receptor protein kinase activity, FAD binding, and NAD/NADH binding, with the alteration of 127, 85, 40, 24, 20, 19, 17, 16, 15, 13, and 12 genes, respectively ( and
Table S3). Whereas, that of down-regulated genes primarily revealed kinase activity, receptor binding, calcium ion binding, GTPase regulator activity, lipid binding, cytokine binding, growth factor binding, and interleukin receptor activity as major sub-categories with corresponding alterations of 80, 76, 76, 62, 55, 34, 21, and 11 genes ( and
Table S4). For the GO: biological process category, up-regulated polyploidy genes primarily sub-categorized into cell cycle (105 genes), cellular component assembly (100 genes), oxidation and reduction (84 genes), carboxylic acid metabolic process (72 genes), lipid metabolic process (69 genes), cell adhesion (68 genes), steroid metabolic process (24 genes), ATP metabolic process (15 genes), and acetyl-CoA metabolic process (12 genes) ( and
Table S3). It is interesting to note that consistent with the status of cycle regulation in polyploid decidual cells
[4], the cell cycle sub-category appeared to reflect several other groups such as chromosome organization, mitotic cell cycle, cell division, nuclear division, DNA packaging, protein-DNA complex assembly, nucleosome organization, DNA replication, regulation of cell size, and chromosome segregation with corresponding alterations of 70, 66, 59, 51, 49, 43, 38, 30, 24, and 19 genes ( and
Table S3). In contrast, the down-regulated polyploidy genes under the GO: biological process category primarily revealed that immune system process (254 genes), cell proliferation (141 genes), apoptosis (135 genes), regulation of cell migration (40 genes), and regulation of cell size (25 genes) are the major affected sub-categories ( and
Table S4). In the case of GO: cellular component, the up-regulated polyploidy genes primarily included mitochondrion (128 genes), extracellular region part (102 genes), chromosome (86 genes), nucleoplasm (68 genes), protein-DNA complex (40 genes), spindle (28 genes), and basement membrane (12 genes) ( and
Table S3), while that of down-regulated genes predominantly comprised intrinsic to plasma membrane (173 genes), cytosol (109 genes), Golgi apparatus (78 genes) and extracellular region part (75 genes), lysosome (36 genes), and basement membrane (11 genes) as the major sub-categories ( and
Table S4). Furthermore, among the rest of the categories, it is interesting to note that the “mouse phenotype” revealed two major sub-categories, reproductive system phenotype (110 genes) and embryonic lethality (109 genes), while the “human phenotype” category primarily implicated “metabolism abnormality” (103 genes) for the up-regulated polyploidy genes (
Table S3). Additionally, the “pathway” category for up-regulated polyploidy genes primarily represented aurora B kinase signaling (17 genes), valine/leucine/isoleucine degradation (15 genes), FOXM1 transcription factor network (14 genes), pyruvate metabolism (13 genes), tryptophan metabolism (12 genes), and citrate cycle (TCA cycle) (12 genes) (
Table S3). In contrast, the down-regulated polyploidy genes under the “pathway” category primarily revealed cytokine-cytokine receptor interaction (49 genes), MAPK signaling pathway (39 genes), and natural killer cell mediated cytotoxicity (33 genes) (
Table S4). Given an essential role for progesterone during decidualization, the “drug” category identified “progesterone” as a major sub-category for both up- and down-regulated polyploidy genes, with corresponding alterations of 165 and 114 genes (
Tables S3 and
S4, respectively). Additionally, growth regulatory molecules such as: estrogens (genistein, estradiol, bisphenol A, diethylstilbestrol, etc.), cancer growth regulating agents (doxorubicin, raloxifene, etc.), oxidants/antioxidants (hydrogen peroxide, resveratrol, paraquat, etc.), or anti-inflammatory agents (indomethacine, corticosterone, etc.) are all highlighted under the “drug category” for both up- or down-regulated polyploidy genes (
Tables S3 and
S4, respectively). Overall, the above analyses suggest that multiple molecular signaling networks (cell/nuclear division cycle, metabolic process, mitochondrial activity, and ATP binding for the up-regulated genes, and apoptosis and immune processes for the down-regulated genes) are affected during the transitional development of decidual cell polyploidy.